touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in Africa?

    touchTALKS for touchINFECTIOUS DISEASES


    Listen to a leading expert from Africa address the issue of vaccine equity in COVID-19 vaccination, including the consequences of vaccine inequity and improving communication with the public.

    The expert:

    • Dr Adidja Amani, University of Yaoundé I, Cameroon

    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Moderna, Inc.  This activity is jointly provided by USF Health and touchIME.

    This episode is Chapter 1 of 2. To listen Chapter 2, where Prof. Nada Melhem addresses COVID-19 vaccine inequity in the Middle East, please click here.

    For further information visit our website www.touchinfectiousdiseases.com 

    38 min
  • The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections

    touchEXPERT OPINIONS for touchINFECTIOUS DISEASES

    Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

    The experts

    • Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada
  • Prof. Dr. med. Oliver Cornely – University of Cologne, Germany
  • Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Moderna. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: https://touchinfectiousdiseasesime.org/mrna-vaccine-platform-respiratory-viral-infections

    34 min
  • The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections

    touchEXPERT OPINIONS for touchRESPIRATORY

    Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

    The experts

    • Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada
  • Prof. Dr. med. Oliver Cornely – University of Cologne, Germany
  • Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Moderna. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: https://touchrespiratoryime.org/mrna-vaccine-platform-respiratory-viral-infections/

    34 min
  • Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer

    touchEXPERT OPINIONS for touchONCOLOGY

    An oncologist, a nurse and a urologist share their insights on the risks and benefits of androgen deprivation therapy, the barriers to equitable care and how to improve treatment adherence for patients with prostate cancer.

     The experts

    • Dr Tanya Dorff, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
  • Ms Brenda Martone, Northwestern Medicine, Chicago, IL, USA
  • Dr Stephen Freedland, Cedars-Sinai, Los Angeles, CA, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Pfizer Inc. and is jointly provided by USF Health and touchIME.

    For further information visit: touchoncology.com


    33 min
  • Optimizing IOL selection Focus on IOL calculations in “difficult” eyes

    touchIN CONVERSATION for touchOPHTHALMOLOGY

    In this activity, listen to ophthalmology experts, Prof. Sumit Garg and Dr Karolinne Rocha, respond to questions from the ophthalmology community on IOL selection in cataract patients, focusing on the preoperative assessment of ocular health, optimizing IOL calculations, and the impact of previous surgeries on lens selection.

    This touchPODCAST is for healthcare professionals only. 

    This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. and is jointly provided by USF Health and touchIME.

    For further information visit our website: touchOPHTHALMOLOGY

    34 min
  • Anti-CGRP antibody preventive treatment of migraine: Practical management

    touchCLINICAL PERSPECTIVES for touchNEUROLOGY

    Listen to two case-based interviews with migraine specialists focusing on preventive treatment of migraine with anti-CGRP antibodies. In the first, a clinical expert shares his perspectives on treatment failure in patients with migraine, providing insights and guidance, while the second discussion considers different clinical scenarios to focus on practical management.

    The experts:

    • Prof. Christian Lampl, Konventhospital Barmherzige Brüder, Linz, Austria
  • Dr Simy Parikh, Thomas Jefferson University Hospital, Philadelphia, PA, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME.

    For further information visit our website:  

    https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/ 

    21 min
  • The complement system in NMOSD and MG: A target for therapeutic benefit?

    touchPANEL DISCUSSION for touchOPHTHALMOLOGY

    Listen to a panel of leading experts discuss  the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.

    The experts

    • Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
  • Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
  • Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    To view this activity in full and to access the downloadable materials please visit: touchOPHTHALMOLOGY

    37 min
  • The complement system in NMOSD and MG: A target for therapeutic benefit?

    touchPANEL DISCUSSION for touchIMMUNOLOGY

    Listen to a panel of leading experts discuss  the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.

    The experts

    • Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
  • Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
  • Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA

    • This touchPODCAST is for HCPs only.

    An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: touchIMMUNOLOGY

    37 min
  • The complement system in NMOSD and MG: A target for therapeutic benefit

    touchPANEL DISCUSSION for touchNEUROLOGY

    Listen to a panel of leading experts discuss  the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.

    The experts

    • Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
  • Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
  • Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA

    • This touchPODCAST is for HCPs only.

    An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: touchNEUROLOGY

    37 min
  • Contemporary insights on sickle cell disease complications and recent advances in therapy

    touchPANEL DISCUSSION for touchRESPIRATORY

    Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy.

    The experts

    • Prof. Biree Andemariam, Farmington, CT, USA
  • Prof. Modupe Idowu, Houston, TX, USA
  • Prof. Mark C Walters, Oakland, CA, USA

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information please visit our website: touchRESPIRATORY

    40 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.